Twelve-Week Treatment Regimen Reduces Facial Redness – Consumer Health News

FRIDAY, July 1, 2022 (HealthDay News) — A 12-week topical therapy routine for facial redness and delicate pores and skin calms infected pores and skin and is nicely-tolerated, based on a examine revealed on-line May 31 within the Journal of Cosmetic Dermatology.

Ellen O. Turner, M.D., from the Dermatology Office in Dallas, carried out a 12-week, open-label medical trial to look at the efficacy and tolerability of a topical facial routine for treating facial redness and delicate pores and skin. Healthy women and men, aged 25 to 60 years, with Fitzpatrick pores and skin varieties I to VI, who had been in search of therapy for reasonable or extreme facial redness had been enrolled. Products had been offered that had been utilized every morning and night.

Turner discovered that at weeks eight and 12, the imply Overall Redness Scale Score improved by 34 and 25 %, respectively. Mild or reasonable enchancment was seen in Global Improvement Scale scores beginning in week two; by week 12, greater than 50 % achieved marked enchancment. All topics agreed or strongly agreed that by week 12 their facial redness was much less noticeable, their pores and skin appeared much less infected, there was enchancment in total pores and skin look, and their pores and skin seemed and felt more healthy. The therapy routine was nicely tolerated.

“The outcomes of this 12-week examine indicated a therapy routine designed to neutralize pores and skin redness, calm infected pores and skin, and supply sunscreen safety was nicely-tolerated and improved the seen and bodily signs of delicate pores and skin,” Turner writes.

The analysis was funded by Colorescience, the producer of the merchandise used within the examine.

Abstract/Full Text